NO20072615L - Biomarkor for hjertesvikt - Google Patents

Biomarkor for hjertesvikt

Info

Publication number
NO20072615L
NO20072615L NO20072615A NO20072615A NO20072615L NO 20072615 L NO20072615 L NO 20072615L NO 20072615 A NO20072615 A NO 20072615A NO 20072615 A NO20072615 A NO 20072615A NO 20072615 L NO20072615 L NO 20072615L
Authority
NO
Norway
Prior art keywords
heart failure
biomarker
patients
ark1
lymphocytes
Prior art date
Application number
NO20072615A
Other languages
English (en)
Norwegian (no)
Inventor
Walter J Koch
Guido Iaccarino
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of NO20072615L publication Critical patent/NO20072615L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20072615A 2004-11-08 2007-05-22 Biomarkor for hjertesvikt NO20072615L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62571904P 2004-11-08 2004-11-08
PCT/US2005/040231 WO2006052857A2 (fr) 2004-11-08 2005-11-04 Biomarqueur pour insuffisance cardiaque

Publications (1)

Publication Number Publication Date
NO20072615L true NO20072615L (no) 2007-08-06

Family

ID=36337092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072615A NO20072615L (no) 2004-11-08 2007-05-22 Biomarkor for hjertesvikt

Country Status (13)

Country Link
US (1) US20090053696A1 (fr)
EP (1) EP1810027A4 (fr)
JP (1) JP2008519283A (fr)
KR (1) KR20070101241A (fr)
CN (1) CN101084439A (fr)
AU (1) AU2005304819A1 (fr)
BR (1) BRPI0515727A (fr)
CA (1) CA2586922A1 (fr)
IL (1) IL183036A0 (fr)
MX (1) MX2007005435A (fr)
NO (1) NO20072615L (fr)
WO (1) WO2006052857A2 (fr)
ZA (1) ZA200703666B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778807B2 (ja) * 2006-02-17 2011-09-21 株式会社リコー 画像形成装置
EP2646572B1 (fr) * 2010-12-01 2017-02-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Diagnostic et traitement d'une insuffisance cardiaque chronique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU727445B2 (en) * 1995-08-18 2000-12-14 Donald W Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
US20090215896A1 (en) * 2004-01-19 2009-08-27 Martek Biosciences Corporation Reelin deficiency or dysfunction and methods related thereto

Also Published As

Publication number Publication date
JP2008519283A (ja) 2008-06-05
BRPI0515727A (pt) 2008-08-05
ZA200703666B (en) 2008-10-29
KR20070101241A (ko) 2007-10-16
EP1810027A4 (fr) 2008-05-28
IL183036A0 (en) 2007-09-20
US20090053696A1 (en) 2009-02-26
WO2006052857A2 (fr) 2006-05-18
AU2005304819A1 (en) 2006-05-18
CA2586922A1 (fr) 2006-05-18
MX2007005435A (es) 2007-07-24
EP1810027A2 (fr) 2007-07-25
CN101084439A (zh) 2007-12-05
WO2006052857A3 (fr) 2006-10-19

Similar Documents

Publication Publication Date Title
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
NO20081198L (no) Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptor
NO20071831L (no) Anvendelse av unormal hendelsesdeteksjonsteknologi for hydrocrackingenheter
WO2008089994A8 (fr) Utilisation de igfbp-7 dans l'évaluation d'une insuffisance cardiaque
NO20093167L (no) System og fremgangsmate for kryssstromings-deteksjon og intervensjon i produksjonsbronner
WO2004096985A3 (fr) Procedes d'evaluation de la diversite biologique
NO20093384L (no) Sykdomsmarkorer
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
WO2005017646A3 (fr) Système, logiciel et procédés pour l'identification de biomarqueurs
WO2008084331A3 (fr) Biomarqeurs pour des troubles rénaux
DK2071216T3 (da) Superplastisk pakning, fortrinsvis til et system med elektrokemiske celler
WO2008003066A3 (fr) Appareil, compositions et procédés d'évaluation de la progression d'une bronchopneumopathie chronique obstructive parmi des conditions de déclin rapide et lent
HK1119771A1 (en) Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
IL166194A (en) Plasma urotensin in human heart failure
WO2005048818A3 (fr) Procede de diagnostic d'une maladie renale
DE602005014778D1 (de) Timp-2 als ziel/marker des versagens von beta-zellen
EP1860430A4 (fr) Procede destine a diagnostiquer des conditions anormales d une unite de detection de la concentration en gaz et appareil destine a diagnostiquer des conditions anormales d une unite de detection de la concentration en gaz
WO2004092322A3 (fr) Dispositifs et dosages pour surveiller/mesurer les dynamiques cellulaires en vue de creer des profils sujets a partir de cellules primaires
WO2010144553A3 (fr) Procédés de diagnostic de la réocclusion de vaisseau sanguin
WO2007079301A3 (fr) Procédé de diagnostic d'une condition ou d'une prédisposition de poids d'un corps
NO20100042L (no) Fremgangsmate og system for stoykansellering ved borefluidtelemetri
NO20072615L (no) Biomarkor for hjertesvikt
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
WO2005034737A3 (fr) Diagnostic et traitement de troubles du reticulum endoplasmique
WO2008153543A3 (fr) Modèle murin fluorescent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application